0020

Wanbangde Pharmaceutical Co., Ltd. (002082)

Market Closed
12 Dec, 06:57
XSHE XSHE
¥
12. 18
+0.07
+0.58%
¥
8.09B Market Cap
- P/E Ratio
0.08% Div Yield
9,594,400 Volume
- Eps
¥ 12.11
Previous Close
Day Range
11.93 12.62
Year Range
4.82 16.66
Want to track 002082 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
0020
002082 Wanbangde Pharmaceutical Co., Ltd.
16 May 2025
-
0.02
0020
002082 Wanbangde Pharmaceutical Co., Ltd.
25 Apr 2024
-
-
0020
002082 Wanbangde Pharmaceutical Co., Ltd.
26 Oct 2023
-
-
0020
002082 Wanbangde Pharmaceutical Co., Ltd.
26 Oct 2016
-
0.08
0020
002082 Wanbangde Pharmaceutical Co., Ltd.
24 Aug 2016
-
0.12
0020
002082 Wanbangde Pharmaceutical Co., Ltd.
26 Apr 2016
-
0.04
0020
002082 Wanbangde Pharmaceutical Co., Ltd.
1 Feb 2016
-
-
0020
002082 Wanbangde Pharmaceutical Co., Ltd.
27 Oct 2015
-
0.09
0020
002082 Wanbangde Pharmaceutical Co., Ltd.
20 Aug 2015
-
0.16
0020
002082 Wanbangde Pharmaceutical Co., Ltd.
27 Apr 2015
-
0.04
0020
002082 Wanbangde Pharmaceutical Co., Ltd.
12 Mar 2015
-
0.13
0020
002082 Wanbangde Pharmaceutical Co., Ltd.
28 Oct 2014
-
0.1
0020
002082 Wanbangde Pharmaceutical Co., Ltd.
19 Aug 2014
-
0.14

002082 Earnings Reports FAQ

What is the earnings per share (EPS) for 002082?

EPS data for 002082 is currently not available, as Wanbangde Pharmaceutical Co., Ltd has not reported recent earnings.

What is the company's earnings growth rate?

Over the past 10 years, the earnings growth rate has been approximately -15.97%, reflecting the 002082's performance and XSHE market conditions.

When is the next earnings release date?

Wanbangde Pharmaceutical Co., Ltd has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Wanbangde Pharmaceutical Co., Ltd are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 002082 at this time, as Wanbangde Pharmaceutical Co., Ltd has no recent EPS data to calculate it.